Jim Watson

Doctor of Medicine,  Mayo Clinic - Rochester 

Location: United States

Consulting Services

Journal Manuscript Career Advice and Mentoring Hospital-Pharmacy-Insurance Grant Submission

Areas Of Interest

Sclerosing Cholangitis, Primary Spasm, Laryngeal Adrenal Hypoplasia, Congenital, with Hypogonadotropic Hypogonadism Xanthomax Ventral Posterior Inferior Thalamic Nucleus Catalog, Union Fibrous Dysplasia, Maxillary Exsanguinating Hemorrhages Iododeoxyuridine Dupuytrens Contracture Subunit, Telomerase Catalytic Pulsed Dye Lasers Chlorofos Abnormality, Torsion Selegiline Hydrochloride Mesenteric Arteries Enterochromaffin Cell Problem-Based Learning Proton-Translocating ATPases, Bacterial Mutations, Opal Nonsense HT29 Cells Gingiva Atrophies Mandibular Condyle beta Aminoethylisothiuronium Dihydroiodide Sodium Heparin Dentoalveolar Abscess, Apical

Professional Narrative

Dr. Jim Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Director Medicine, Amgen 2019
Executive Director, Amgen 2012

Education

Doctor of medicine, Weill Medical College 2019
Doctor of medicine, Yale School of Medicine 1989

Referees

Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02